See more : Tellurian Inc. 8.25% Senior Not (TELZ) Income Statement Analysis – Financial Results
Complete financial analysis of Anhui Huaertai Chemical Co., Ltd. (001217.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Anhui Huaertai Chemical Co., Ltd., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Cyclone Metals Limited (CLE.AX) Income Statement Analysis – Financial Results
- Population Health Investment Co., Inc. (PHICW) Income Statement Analysis – Financial Results
- Willis Towers Watson Public Limited Company (WLTW) Income Statement Analysis – Financial Results
- Autoneum Holding AG (0QOB.L) Income Statement Analysis – Financial Results
- Spok Holdings, Inc. (SPOK) Income Statement Analysis – Financial Results
Anhui Huaertai Chemical Co., Ltd. (001217.SZ)
About Anhui Huaertai Chemical Co., Ltd.
Anhui Huaertai Chemical Co., Ltd. engages in the research and development, production, and sale of chemical products. It offers ammonium sulfate, hydrogen peroxide, 65 niacin, sulfur trioxide, melamine, concentrated sulfuric and nitric acid, oleum, industrial sodium nitrite and nitrate, liquid ammonia, ammonium bicarbonate, and methanol. The company was founded in 2000 and is based in Chizhou, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.79B | 2.10B | 1.89B | 1.15B | 1.26B | 1.27B | 1.12B |
| Cost of Revenue | 1.51B | 1.74B | 1.29B | 877.91M | 921.29M | 973.59M | 845.09M |
| Gross Profit | 286.25M | 358.17M | 606.47M | 269.64M | 335.62M | 301.03M | 278.35M |
| Gross Profit Ratio | 15.97% | 17.04% | 32.03% | 23.50% | 26.70% | 23.62% | 24.78% |
| Research & Development | 38.59M | 64.48M | 60.25M | 41.11M | 43.89M | 42.60M | 33.48M |
| General & Administrative | 20.54M | 20.47M | 29.68M | 10.29M | 7.11M | 5.71M | 24.06M |
| Selling & Marketing | 1.14M | 6.55M | 6.07M | 5.24M | 89.12M | 85.37M | 86.94M |
| SG&A | 50.03M | 27.02M | 35.76M | 15.53M | 96.23M | 91.08M | 110.99M |
| Other Expenses | 15.50M | 35.29M | 32.44M | 22.92M | 19.94M | 8.38M | -3.26M |
| Operating Expenses | 104.12M | 126.80M | 128.44M | 79.57M | 160.06M | 155.30M | 149.43M |
| Cost & Expenses | 1.61B | 1.87B | 1.42B | 957.48M | 1.08B | 1.13B | 994.52M |
| Interest Income | 4.32M | 5.74M | 2.08M | 117.07K | 681.45K | 968.98K | 0.00 |
| Interest Expense | 651.54K | 5.16M | 583.92K | 1.43M | 5.59M | 13.21M | 0.00 |
| Depreciation & Amortization | 116.79M | 154.89M | 114.01M | 94.72M | 109.60M | 90.07M | 76.40M |
| EBITDA | 298.22M | 319.28M | 564.60M | 270.06M | 259.65M | 229.54M | 194.26M |
| EBITDA Ratio | 16.64% | 17.81% | 29.85% | 23.75% | 20.34% | 17.48% | 18.57% |
| Operating Income | 182.13M | 243.80M | 478.85M | 186.20M | 171.32M | 130.12M | 121.33M |
| Operating Income Ratio | 10.16% | 11.60% | 25.29% | 16.23% | 13.63% | 10.21% | 10.80% |
| Total Other Income/Expenses | -695.72K | 8.80M | 3.15M | 7.27M | -2.88M | -4.14M | -3.26M |
| Income Before Tax | 181.43M | 252.59M | 482.00M | 193.47M | 168.44M | 125.98M | 118.06M |
| Income Before Tax Ratio | 10.13% | 12.02% | 25.45% | 16.86% | 13.40% | 9.88% | 10.51% |
| Income Tax Expense | 23.16M | 32.83M | 66.41M | 25.53M | 22.30M | 16.06M | 716.18K |
| Net Income | 158.28M | 219.77M | 415.59M | 167.95M | 146.14M | 109.92M | 117.35M |
| Net Income Ratio | 8.83% | 10.46% | 21.95% | 14.64% | 11.63% | 8.62% | 10.45% |
| EPS | 0.48 | 0.66 | 1.25 | 0.51 | 0.44 | 0.44 | 0.47 |
| EPS Diluted | 0.48 | 0.66 | 1.25 | 0.51 | 0.44 | 0.44 | 0.47 |
| Weighted Avg Shares Out | 329.74M | 331.87M | 331.87M | 331.87M | 331.87M | 249.81M | 249.68M |
| Weighted Avg Shares Out (Dil) | 329.74M | 331.87M | 331.87M | 331.87M | 331.87M | 249.81M | 249.68M |
Source: https://incomestatements.info
Category: Stock Reports